IDiyas

For the Inventor, By the Inventor

Ely, United Kingdom

Adrian St Clair Brown

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 85(Granted Patents)


Company Filing History:

goldMedal8 out of 173 
 
Exelixis, Inc.
 patents

Years Active: 2014-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12275706 - Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer (2025-04-14),
2. 11254649 - Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone (2022-02-22),
3. 11098015 - Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer (2021-08-24),
4. 11091440 - Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N'-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer (2021-08-17),
5. 11091439 - Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer (2021-08-17),
6. 10590102 - Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone (2020-03-17),
7. 9809549 - Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer (2017-11-07),
8. 8877776 - (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2014-11-04),

Title: The Innovative Contributions of Adrian St Clair Brown

Introduction

Adrian St Clair Brown is a notable inventor based in Ely, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 8 patents to his name, his work continues to impact the medical community.

Latest Patents

Among his latest patents is the malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide. This patent discloses various malate salts and their crystalline forms, which are essential for treating cancer. Another significant patent is the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl][3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl]-methanone. This invention also relates to pharmaceutical compositions and methods for treating cancers.

Career Highlights

Adrian St Clair Brown is currently associated with Exelixis, Inc., a company known for its focus on innovative cancer therapies. His work at Exelixis has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Peter Lamb and William P Gallagher, further enhancing the impact of his work in the field.

Conclusion

Adrian St Clair Brown's innovative contributions to cancer treatment through his patents and collaborations highlight his importance in the pharmaceutical industry. His ongoing work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…